首页> 外文期刊>Bioorganic and medicinal chemistry >Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate.
【24h】

Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate.

机译:硫代氨基甲酸酯作为非核苷HIV-1逆转录酶抑制剂。第2部分:O-(2-苯乙基)-N-苯基硫代氨基甲酸酯类似物的平行合成,分子建模和构效关系研究。

获取原文
获取原文并翻译 | 示例
           

摘要

To acquire further insight into the structure-activity relationship (SAR) of the thiocarbamates (TCs) described in the preceding work, 57 analogues of the lead compound O-(2-phenylethyl)-N-phenylthiocarbamate I were prepared by parallel solution-phase synthesis. We varied the 2-phenylethyl moiety (mono-substitution on the phenyl ring and modification of the ethyl linker), keeping constant the N-phenyl ring substitutions which have given the best results in the previous series. Most of the new TCs inhibited wild-type HIV-1 at micro- and nanomolar concentrations in MT-4 cell-based assays. Some TCs were also active at micromolar concentrations against the Y181C and/or K103N/Y181C resistant mutants. The SARs were rationalized by docking simulations.
机译:为了进一步了解先前工作中描述的硫代氨基甲酸酯(TC)的结构活性关系(SAR),通过平行溶液相制备了铅化合物O-(2-苯乙基)-N-苯基硫代氨基甲酸酯I的57个类似物合成。我们改变了2-苯乙基部分(苯环上的单取代基和乙基连接基的修饰),使N-苯环取代保持不变,这在之前的系列中给出了最好的结果。在基于MT-4细胞的测定中,大多数新的TC在微纳摩尔浓度下都抑制了野生型HIV-1。一些TC在微摩尔浓度下对Y181C和/或K103N / Y181C耐药突变体也有活性。通过对接模拟使SAR合理化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号